Regis Corporation Q1 2026 Earnings Positive EPS Achieved Amid Limited Revenue Disclosure ALGS Q1 2026 Earnings NarrowerThanExpected Loss as Aligos Therapeutics Advances Pipeline Galectin Therapeutics Q1 2026 Earnings EPS Misses Estimates Stock Rallies on Operational Progress NWBI Q1 2026 Earnings Earnings Surpass Estimates as Stock Declines Amid Broader Market Pressure NICE Q1 2026 Earnings EPS Surpasses Estimates as Stock Declines ARAY Q1 2026 Earnings EPS Misses Estimates Stock Surges Despite WiderThanExpected Loss